Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Futura Extends Europe Licensing Agreement With Cooper For Eroxon ED Gel

Jan 16 2024

• By David Ridley

Deal — • Source: Shutterstock

Related Content

‘A Phenomenon’ – Futura’s Eroxon ED Gel Gets Off To Flying Start In The UK

Jul 05 2023

OTC Marketing Awards 2023: What The Judges Said About The Leading Entries

Nov 24 2023

Sanofi Launches OTC Cialis In UK

Jun 12 2023

Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch

Oct 19 2021

Cooper Consumer Health Poised To Double In Size With Viatris Acquisition

Oct 03 2023

Viatris Retains Interest In OTC As It Spies Switch Opportunities

Oct 04 2023

Haleon Enters US OTC Erectile Dysfunction Race With Futura Deal

Jul 19 2023

Female Sexual Dysfunction, China, Next On The Agenda For Eroxon Creator Futura

Nov 07 2023

Futura Pens Deal With Cooper To Launch Erectile Dysfunction Gel In Europe

May 26 2022

Sanofi Hopes UK Cialis Launch Will Illustrate US Switch Potential

May 03 2023

Viatris Puts OTC Business Up For Sale

Nov 16 2022

Related Companies

Futura Medical plc

Viatris Inc.

Haleon plc

Additional Topics

Europe Advertising, Marketing & Sales Business Strategies Companies Consumer Deals Distribution Intellectual Property OTC Drugs OTC Devices StartUps and SMEs Women's Health

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.